Box Life Magazine says new Oxford research paints a sobering picture of GLP-1 weight loss drugs like Ozempic and Wegovy, but its post gives no findings and is gated behind comment bait.
Recap by typeshit. Post by @boxlifemagazine on Instagram.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Drunk Elephant, Lion Pose and Jennifer Aniston's LolaVie are among brands adding peptides, while skin experts talk up GHK-Cu's buzz.
Citing the Wall Street Journal, Daily Mail Australia says personal injury firm Weitz and Luxenberg brought nearly all of the claims against the Wegovy and Ozempic maker.
Loading…